Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

Tabless Tube Holder

By Drug Discovery Trends Editor | August 22, 2012

Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, introduces two tabless tube holder accessories for its Strata and Strata-X lines of silica-based and polymeric solid phase extraction (SPE) sorbents. These accessories hold SPE tubes in 96-well spacing to integrate with automated systems. All Strata and Strata-X products are now available in the tabless 1 mL tube format, enabling the user to arrange multiple sorbents within the holders, adding flexibility for method development. Users can also remove and replace a single SPE tube should they make an error, which cannot be done with standard 96-well SPE plates. The Tabless Tube Holders are compatible with the Phenomenex vacuum manifold as well as positive pressure systems.

“Our new Tabless Tube Holders are easy to use and add flexibility to the workflow options using our Strata and Strata-X sorbents,” comments Erica Pike, brand manager for Phenomenex. “Our growing line of Strata and Strata-X products meets the sample preparation needs of a wide range of applications, including complex biological matrices.”

Strata and Strata-X SPE sorbents simplify the method development process for fast and efficient sample preparation prior to chromatography. They remove unwanted contaminants, including phospholipids, and are offered in a number of unique selectivities to cover a diverse range of analytes.

Phenomenex Inc.


Filed Under: Drug Discovery

 

Related Articles Read More >

Takeda Pharmaceutical in the Drug Discovery & Development Pharma 50
Takeda’s Takhzyro fares well in pediatric hereditary angioedema study
Novartis in the Pharma 50
Novartis to cut up to 8,000 positions
Gilead Sciences in the Drug Discovery & Development Pharma 50
Gilead resubmits application to FDA for twice-yearly HIV drug lenacapavir
George Floyd mural
How the pandemic and George Floyd made clinical trial diversity a priority

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MASSDEVICE
  • DEVICETALKS
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • MEDTECH 100
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50